|
The Regulation on Hemp Cultivation for Medicinal Active Ingredient Production and Its Control (“Regulation”), published in the Official Gazette No. 32661 on September 13, 2024, regulates the procedures and principles regarding the procedures to be applied within the scope of cannabis cultivation to obtain pharmaceutical active ingredients and the duties and responsibilities regarding the necessary controls. In summary, the Regulation sets out the following procedures and principles regarding the application process:
Within the scope of the Regulation, detailed regulations are included regarding the characteristics of the facilities where hemp cultivation will be carried out and the responsibilities of real or legal persons who will cultivate hemp as well. In this context, the following issues are regulated in summary:
The control committee comprises representatives from relevant institutions and is tasked with inspecting facilities in accordance with the provisions set forth in the Regulation. Individuals and institutions holding a permit who wish to discontinue production must apply to the TMO, which will then issue a cancellation decision on behalf of the Ministry. In the event of cancellation, the control committee will oversee the destruction of the plant materials and residues present at the facility. TMO, regulates the domestic and international sale of hemp. TMO, collects and verifies the necessary permits and documents for export operations and reports them to the relevant authorities. You can access the text of the Regulation on Hemp Cultivation for Medicinal Active Ingredient Production and Its Control, which came into effect on September 13, 2024, here. |